Korea Disease Control and Prevention Agency

Northwell Launches $500 Million Initiative to Expand Pediatric Mental Health Services and Access to Care for Children and Teens

Retrieved on: 
Mercredi, novembre 8, 2023
Managed Care, Family, Philanthropy, Consumer, Mental Health, Hospitals, Teens, Fund Raising, Parenting, Children, Practice Management, Health, Mental, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Adolescence, Ageing, Education, Cohen, Korea Disease Control and Prevention Agency, Impossible, Zucker Hillside Hospital, MD, Hofstra University, Psychiatry, Island, Mental health, Research, Multimedia, Pediatrics, Donald, Disorder, Student, Hospital, Stigma, Blumenfeld, Suicide, Depression, Citi Field, Anxiety, Patient, Bed, Death, Transplant, Parent, Nursing, Northwell Health, Child

The future Child and Adolescent Mental Health Pavilion will be connected to Cohen Children’s Medical Center and Zucker Hillside Hospital , Northwell’s adult mental health facility, in Queens, NY.

Key Points: 
  • The future Child and Adolescent Mental Health Pavilion will be connected to Cohen Children’s Medical Center and Zucker Hillside Hospital , Northwell’s adult mental health facility, in Queens, NY.
  • The approximately 200,000-square-foot building will fully integrate physical and mental health care for children and serve as a destination program for patients across the country.
  • The initiative will bring together Northwell’s extensive expertise in children’s clinical care, mental health, leading-edge research, education and medical training to set a new standard for care.
  • This investment will break the archaic siloed approach in which physical health is addressed at one facility and mental health at another by fully integrating physical and mental health care for children.”
    Through Cohen Children’s Medical Center, Northwell currently operates pediatric behavioral health urgent care centers in Nassau and Suffolk counties.

EOM Pharmaceutical Holdings Provides an Update on its Lead Drug Candidate EOM613

Retrieved on: 
Mardi, novembre 7, 2023
IND, Glossary, Incidence, Gastrointestinal tract, Patent, Korea Disease Control and Prevention Agency, Fungal infection, Cachexia, Toxicology, OTC, Prevalence, MD, Doctor of Philosophy, Ulcerative colitis, Inflammatory bowel disease, Crohn's disease, CDC, Disease, Clinical trial, COVID-19, Risk, EOM, Effectiveness, IBD, Patent pending, Patient, Pharmaceutical industry, Vaccine, AIDS

MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613.

Key Points: 
  • MONTVALE, N.J., Nov. 7, 2023 /PRNewswire/ -- EOM Pharmaceutical Holdings, Inc. (OTC: IMUC) ("EOM") today provides an update on its clinical program for its lead drug candidate EOM613.
  • In light of these clinical trial results, the company is currently preparing to initiate an EOM613 clinical program in Crohn's disease.
  • "In previous clinical trials in AIDS, cancer cachexia and COVID-19 patients, EOM613 was demonstrated to be well-tolerated, even in very sick patients.
  • "EOM's priority is to initiate a clinical program in inflammatory bowel disease as soon as possible," added Irach B. Taraporewala, PhD, Chief Executive Officer of EOM.

NEW REPORT: Public Health Departments Lack Funding for Hepatitis Surveillance Systems

Retrieved on: 
Vendredi, novembre 3, 2023
Associate, Infection, Korea Disease Control and Prevention Agency, Key finding attacks, Public health, White House, Hepatitis, Hepatitis C, Congress, Mortality, Viral hepatitis, Data collection, Local, HIV, Doctor of Philosophy, STD, Data, Data science, FTE, CDC, Gender identity, Disease, Risk, Health equity, Joe Biden, Emory, White, Public, Hepatitis B, D.C, Vaccine, Pharmaceutical industry, Epidemiology

~ HepVu and NASTAD, leading viral hepatitis organizations, release second annual assessment of viral surveillance practices across U.S. jurisdictions ~

Key Points: 
  • ~ HepVu and NASTAD, leading viral hepatitis organizations, release second annual assessment of viral surveillance practices across U.S. jurisdictions ~
    Washington, D.C. – Today, HepVu and NASTAD , leading viral hepatitis organizations, released a new report showing U.S. jurisdictions continue to lack funding and resources needed to effectively implement viral hepatitis surveillance programs.
  • A robust surveillance system allows the U.S. to monitor disease burden and disparities and mount an effective public health response to eliminate viral hepatitis in the U.S.
  • Robust viral hepatitis surveillance systems are critical to guide strategies for prevention and treatment of infections and to reduce viral hepatitis-related disparities and health inequities.
  • Prior to 2021, only 14 states received federal funding specifically for viral hepatitis surveillance.

Aledade Celebrates the Election of Dr. Jen Brull as President of the American Academy of Family Physicians

Retrieved on: 
Vendredi, octobre 27, 2023
Modern Healthcare, HIT, Korea Disease Control and Prevention Agency, AAFP, Physician, Congress, Office of the National Coordinator for Health Information Technology, Health, Astra, American Academy, American Academy of Family Physicians, Patient, Pharmaceutical industry, Nursing, MD

Founded in 1947, the AAFP represents 129,600 physicians and medical students nationwide. It is the largest medical society devoted solely to primary care, advocating on behalf of family physicians across the country who conduct approximately one in five office visits -- that’s 192 million visits annually or 48 percent more than the next most visited medical specialty.

Key Points: 
  • Bethesda, MD, Oct. 27, 2023 (GLOBE NEWSWIRE) -- Today, Aledade announced that its Vice President of Clinical Engagement, and a former Aledade ACO physician, Dr. Jen Brull, was elected president of the American Academy of Family Physicians during the organization’s Congress of Delegates.
  • “I’m deeply honored to have been entrusted with this role by so many family medicine friends and colleagues,” said Dr. Brull.
  • My guiding star has always been, and will continue to be, bringing excellent primary care to patients all across the country.
  • Jen Brull is a true servant leader,” said Farzad Mostashari, CEO and co-founder of Aledade.

Second Shatterproof Walk Will Continue Shatterproof’s National Campaign to End the Stigma of Addiction

Retrieved on: 
Jeudi, novembre 2, 2023
General Health, Mental Health, Health, Foundation, Philanthropy, Policy, Korea Disease Control and Prevention Agency, Hope, SUD, Light, Friends, Death, CDC, Disease, Fentanyl, Suds, Pharmaceutical industry, Online shopping

During this event, the Los Angeles community will come together and support families, friends, neighbors and colleagues impacted by the disease of addiction.

Key Points: 
  • During this event, the Los Angeles community will come together and support families, friends, neighbors and colleagues impacted by the disease of addiction.
  • The Shatterproof Walk gives the community the opportunity to bring the disease of addiction into the light and share inspiring stories of hope and recovery.
  • Participants will unite to engage in several activities geared toward ending the stigma associated with SUDs, including a community walk.
  • For more information or to register for the Shatterproof Walk event, visit: https://shatterproofwalk.org/la
    To participate in a Virtual Walk Your Way, visit https://shatterproofwalk.org

Key Drivers of Growth in Orthopedic Regenerative Surgical Products Market: Aging Population and Technological Innovations - ResearchAndMarkets.com

Retrieved on: 
Lundi, octobre 30, 2023
Surgery, Health, FDA, Ageing, IND, Korea Disease Control and Prevention Agency, Obesity, Abdominal ultrasonography, Prevalence, Umbilical cord, Arthralgia, R, Trauma, Application, Allotransplantation, CDC, Growth, COVID-19, Risk, Hospital, Osteoarthritis, Fibromyalgia, USD, Therapy, Clifton Springs Hospital & Clinic, Pain, Gout, Arthritis, Pharmaceutical industry

The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030.

Key Points: 
  • The global orthopedic regenerative surgical products market size is anticipated to reach USD 5.63 billion by 2030.
  • The primary factors boosting the market growth include the growing older population, easy availability of orthopedic treatments & procedures, and technological advancements.
  • For instance, osteoarthritis, an orthopedic ailment, has been considered the major factor of chronic disability in the geriatric population (aged above 70 years).
  • Thus, the growing prevalence of orthopedic ailments and the rising aging population & obesity cases are expected to drive market growth.

The World's First "Recombinant Anthrax Vaccine": GC Biopharma applies for MFDS Approval

Retrieved on: 
Lundi, novembre 6, 2023
MFDS, Korea Disease Control and Prevention Agency, KDCA, Incidence, Infection, Vaccine, Bioterrorism, Bacillus anthracis, Research, Cell, Protein, Volunteering, Development, Korean Ministry of Culture, Disulfiram-like drug, Phase, Antibody, Marketing, Medicine, Public, Anthrax, Safety, Public and private bills, DNA, Food

YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug Safety (MFDS).

Key Points: 
  • YONGIN, South Korea, Nov. 5, 2023 /PRNewswire/ -- GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of "GC1109", an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA), to the Korean Ministry of Food and Drug Safety (MFDS).
  • If approved, "GC1109" will be the world's first recombinant anthrax vaccine.
  • In order to prepare against potential bioterrorism and consequent national crisis, GC Biopharma, under the research project supported by KDCA, has been working on developing a recombinant vaccine for anthrax since 2002.
  • GC Biopharma stated, "We believe in the significance of our journey to localize the anthrax vaccine in terms of securing vaccine sovereignty, while promoting public health and national security.

National Survey Shows Drop in E-Cigarette Use Among High School Students

Retrieved on: 
Jeudi, novembre 2, 2023
FDA, Sale, Fruit, Physical examination, Food, Health, Korea Disease Control and Prevention Agency, Tobacco smoking, Regulation of tobacco by the U.S. Food and Drug Administration, Conflict, Center for Tobacco Products, Ice, CMP, CDC, Candy, Public, Heated tobacco product, Menthol, JUUL, Tobacco

SILVER SPRING, Md., Nov. 2, 2023 /PRNewswire/ -- Today, the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention (CDC), released data from the 2023 National Youth Tobacco Survey (NYTS) on tobacco product use among U.S. youth. The findings, which were collected between March and June 2023, show that 10% of U.S. middle and high school students (2.8 million youth) reported current use of any tobacco product.

Key Points: 
  • Among U.S. high school students, current overall tobacco product use declined during 2022-2023 (16.5% to 12.6%).
  • Among high school students, declines in current use were also observed during 2022-2023 for cigars and overall combustible tobacco smoking, representing all-time lows.
  • Although a decrease in e-cigarette use was observed among high school students, among middle school students there was an increase in current overall tobacco product use (4.5% to 6.6%) and multiple tobacco product use (1.5% to 2.5%).
  • E-cigarettes remained the most commonly used tobacco product among both high school and middle school students for the 10th year in a row.

ASHA Announces New Developmental Milestones for Children Ages Birth to 5

Retrieved on: 
Mercredi, novembre 1, 2023
Communication, Child, ASHA, Vocalization, Korea Disease Control and Prevention Agency, Family, Marie Cassidy, Human, Hearing loss, Gag, Pediatrics, Audiology, DSM-IV codes, Choking, Doctor of Philosophy, Dysphagia, Speech, Learning, Database, Caregiver, NIDCD, COVID-19, American Speech–Language–Hearing Association, Disorder, School, Speech–language pathology, Brain, National Institute on Deafness and Other Communication Disorders, Language, Hearing, Deafness, Parent, Toy, Birth control, Nursing

ROCKVILLE, Md., Nov. 1, 2023 /PRNewswire/ -- The American Speech-Language-Hearing Association (ASHA) announces today the free, online availability of new checklists that detail communication (speech, language, and hearing) milestones for children ages birth to 5 years as well as feeding and swallowing milestones for children ages birth to 3 years. These milestones provide parents and caregivers with a roadmap of what to expect during their child's early years of life—and can alert them to the early signs of a potential developmental delay or disorder.

Key Points: 
  • Ideally, intervention will occur when the brain is most flexible—which is between birth and 3 years.
  • To inform the new communication checklists, the Association considered the latest peer-reviewed studies for children ages birth to 5 years who are learning English in the United States.
  • Informing the public about milestones and the signs of possible disorders is a critical way to identify and treat more children with developmental disorders at earlier ages.
  • Examples of ASHA's communication milestones for children ages birth to 5 years include the following:
    Vocalizes different vowel sounds—sometimes combined with a consonant—like uuuuuummm, aaaaaaagoo, or daaaaaaaaaa (4 to 6 months).

The Ad Council, CDC, National Council for Mental Wellbeing and Shatterproof Launch Joint Effort to Inspire Millions Living with or At Risk for Substance Use Disorders to Begin their Recovery Journeys

Retrieved on: 
Mercredi, novembre 1, 2023
National Council, Government, HHS, Policy, Ageing, Love, PSA, NYSE, Unitary state, Korea Disease Control and Prevention Agency, Hope, National Survey on Drug Use and Health, Naloxone, SUD, Mental health, Multimedia, Mental, Smokey Bear, Advertising, Quality of life, Drug overdose, CDC, Council, Factitious disorder, Risk, Marketing, Ad Council, PSAS, SAMHSA, Partnership, Safety, Office of Inspector General, U.S. Department of Health and Human Services, Social change, Anxiety, Depression, KFF, Suds, Hearing, State, Dietary supplement, Nursing, Tourism, Pharmaceutical industry, Vaccine, Black, Health, The 39 Clues, Accenture

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- The Ad Council, in partnership with the Centers for Disease Control and Prevention (CDC), National Council for Mental Wellbeing and Shatterproof, is inspiring millions to "Start With Hope" in a national public service advertisement (PSA) campaign. This vital new effort aims to deliver a message of hope to those living with substance use disorders (SUDs) as well as those at risk of developing a SUD, with a focus on supporting Black and Hispanic/Latinx populations, connecting them with harm reduction strategies and treatment resources to start their journeys to wellbeing and recovery.

Key Points: 
  • Due to compounding inequities including stigma, accessibility barriers and racial bias, these communities often have lower access to substance use treatment services.
  • It is critical that individuals can access culturally-responsive harm reduction and treatment options to support their paths toward wellbeing and recovery.
  • Hope can also serve as a strong predictor of outcomes focused on well-being and quality of life.
  • If you are experiencing anxiety, depression, or a substance use disorder, text SHATTERPROOF to 741741 for help.